Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-061454
Filing Date
2025-03-24
Accepted
2025-03-24 17:13:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d915849d424b3.htm 424B3 140834
2 GRAPHIC g915849dsp22.jpg GRAPHIC 7697
  Complete submission text file 0001193125-25-061454.txt   152565
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283150 | Film No.: 25765054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)